Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer, prostate ...

For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of ...

Indicators of a response to radiation therapy include pain relief and a return to baseline function or improved function. Patients may experience some relief of symptoms within a few days after ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The ...

Accord BioPharma received FDA approval for 420mg HERCESSI, a biosimilar to Herceptin to treat various kinds of ...

The guidance is geared towards sponsors who conduct oncology therapy trials in more than one country under a single protocol.

In a report released yesterday, Sachin Jain from Bank of America Securities reiterated a Buy rating on Genmab A/S (0MGB – Research ...

EDAP TMS SA, the global leader in robotic energy-based therapies, and Avenda Health (“Avenda”), a leading AI healthcare ...

Growing interest in the technology plus a novel tracer on the way may induce change in coming years, says Marcelo Di Carli.

Following its initial approval at 150 mg, trastuzumab-strf has also been approved at 420 mg for the treatment of several HER2 ...